Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Automation, Laboratory | 2 | 2026 | 17 | 1.410 |
Why?
|
| Medical Waste | 1 | 2026 | 2 | 0.970 |
Why?
|
| Medical Waste Disposal | 1 | 2026 | 6 | 0.960 |
Why?
|
| Onchocerca volvulus | 1 | 2020 | 16 | 0.640 |
Why?
|
| Onchocerciasis | 1 | 2020 | 22 | 0.630 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2020 | 87 | 0.600 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2020 | 127 | 0.560 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2015 | 51 | 0.440 |
Why?
|
| Occupational Health | 2 | 2005 | 46 | 0.440 |
Why?
|
| Nigeria | 9 | 2012 | 69 | 0.410 |
Why?
|
| Point-of-Care Systems | 1 | 2015 | 208 | 0.370 |
Why?
|
| Alcoholic Beverages | 1 | 2010 | 16 | 0.320 |
Why?
|
| Cholinesterases | 2 | 2007 | 6 | 0.310 |
Why?
|
| Organophosphorus Compounds | 2 | 2007 | 26 | 0.310 |
Why?
|
| Hospitals, University | 2 | 2007 | 100 | 0.300 |
Why?
|
| Occupational Diseases | 2 | 2007 | 77 | 0.290 |
Why?
|
| Follistatin | 1 | 2008 | 37 | 0.280 |
Why?
|
| Occupational Exposure | 2 | 2007 | 138 | 0.280 |
Why?
|
| Activins | 1 | 2008 | 71 | 0.280 |
Why?
|
| Developing Countries | 3 | 2005 | 302 | 0.280 |
Why?
|
| Inhibins | 1 | 2008 | 85 | 0.270 |
Why?
|
| Alcoholism | 1 | 2010 | 244 | 0.270 |
Why?
|
| Alkaline Phosphatase | 1 | 2007 | 95 | 0.270 |
Why?
|
| Aspartic Acid | 1 | 2007 | 78 | 0.260 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 2603 | 0.260 |
Why?
|
| Alanine Transaminase | 1 | 2007 | 157 | 0.260 |
Why?
|
| Diabetes Mellitus | 1 | 2015 | 890 | 0.250 |
Why?
|
| Biomarkers | 3 | 2013 | 3394 | 0.250 |
Why?
|
| Reproduction | 1 | 2008 | 213 | 0.250 |
Why?
|
| Industry | 1 | 2006 | 28 | 0.240 |
Why?
|
| Antioxidants | 3 | 2013 | 334 | 0.240 |
Why?
|
| Laboratories, Hospital | 1 | 2005 | 24 | 0.240 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2005 | 59 | 0.230 |
Why?
|
| Erythrocytes | 1 | 2006 | 187 | 0.230 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2005 | 217 | 0.210 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2025 | 143 | 0.210 |
Why?
|
| Clinical Medicine | 1 | 2004 | 20 | 0.210 |
Why?
|
| Liver Diseases | 1 | 2007 | 383 | 0.200 |
Why?
|
| Laboratories | 1 | 2004 | 79 | 0.200 |
Why?
|
| Safety | 1 | 2004 | 213 | 0.200 |
Why?
|
| Hepatitis C | 1 | 2005 | 388 | 0.180 |
Why?
|
| HIV Infections | 3 | 2010 | 2013 | 0.170 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2005 | 489 | 0.160 |
Why?
|
| Tomography, Emission-Computed | 1 | 2020 | 35 | 0.160 |
Why?
|
| Radiopharmaceuticals | 1 | 2020 | 163 | 0.150 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2005 | 906 | 0.150 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2020 | 125 | 0.150 |
Why?
|
| Hospitals, Teaching | 3 | 2010 | 108 | 0.130 |
Why?
|
| Adult | 10 | 2020 | 31131 | 0.130 |
Why?
|
| Case-Control Studies | 5 | 2012 | 3389 | 0.120 |
Why?
|
| Humans | 16 | 2026 | 130447 | 0.120 |
Why?
|
| Biopsy | 1 | 2020 | 1237 | 0.120 |
Why?
|
| Vitamin E | 2 | 2012 | 63 | 0.120 |
Why?
|
| Ascorbic Acid | 2 | 2012 | 72 | 0.120 |
Why?
|
| Pediatrics | 1 | 2025 | 1244 | 0.110 |
Why?
|
| Quality Control | 1 | 2015 | 115 | 0.110 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 1892 | 0.110 |
Why?
|
| Oxidants | 1 | 2013 | 25 | 0.100 |
Why?
|
| Free Radicals | 1 | 2012 | 35 | 0.100 |
Why?
|
| Vitamins | 1 | 2012 | 112 | 0.090 |
Why?
|
| Immunity, Innate | 1 | 2013 | 405 | 0.080 |
Why?
|
| Alcoholics | 1 | 2010 | 2 | 0.080 |
Why?
|
| United States | 1 | 2026 | 11820 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 2112 | 0.080 |
Why?
|
| Albuminuria | 1 | 2010 | 105 | 0.080 |
Why?
|
| Chagas Disease | 1 | 2013 | 324 | 0.070 |
Why?
|
| Metabolic Syndrome | 1 | 2012 | 366 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2010 | 1451 | 0.070 |
Why?
|
| Ethanol | 1 | 2010 | 164 | 0.070 |
Why?
|
| Middle Aged | 7 | 2013 | 28376 | 0.070 |
Why?
|
| Creatinine | 1 | 2010 | 397 | 0.070 |
Why?
|
| Female | 9 | 2020 | 70337 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 2925 | 0.070 |
Why?
|
| Liver Function Tests | 1 | 2007 | 98 | 0.070 |
Why?
|
| Infertility | 1 | 2008 | 69 | 0.070 |
Why?
|
| Air Pollutants, Occupational | 1 | 2007 | 24 | 0.070 |
Why?
|
| Risk Assessment | 2 | 2006 | 3684 | 0.060 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2007 | 87 | 0.060 |
Why?
|
| Male | 9 | 2013 | 64550 | 0.060 |
Why?
|
| Medical Laboratory Personnel | 1 | 2005 | 14 | 0.060 |
Why?
|
| Seroepidemiologic Studies | 1 | 2005 | 165 | 0.060 |
Why?
|
| Hepatitis B | 1 | 2005 | 172 | 0.050 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2005 | 253 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 1443 | 0.040 |
Why?
|
| Adolescent | 3 | 2010 | 20754 | 0.040 |
Why?
|
| Animals | 1 | 2020 | 33924 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2007 | 5076 | 0.030 |
Why?
|
| Blood Glucose | 2 | 2012 | 1105 | 0.030 |
Why?
|
| Time Factors | 1 | 2006 | 6187 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2005 | 4001 | 0.030 |
Why?
|
| Pregnancy | 1 | 2005 | 7429 | 0.020 |
Why?
|
| Waist Circumference | 1 | 2012 | 93 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2012 | 236 | 0.020 |
Why?
|
| Aged | 3 | 2013 | 20888 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2010 | 315 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2007 | 17652 | 0.020 |
Why?
|
| Age Distribution | 1 | 2010 | 424 | 0.020 |
Why?
|
| Lipids | 1 | 2012 | 563 | 0.020 |
Why?
|
| Child | 2 | 2025 | 26172 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2010 | 6420 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2012 | 798 | 0.020 |
Why?
|
| Chemical Industry | 1 | 2007 | 7 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2012 | 1337 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2010 | 568 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2010 | 472 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2012 | 1676 | 0.010 |
Why?
|
| Prevalence | 1 | 2010 | 2684 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2010 | 8529 | 0.010 |
Why?
|
| Risk Factors | 1 | 2010 | 10940 | 0.010 |
Why?
|
| Infant | 1 | 2010 | 13285 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2010 | 14989 | 0.010 |
Why?
|